Gainers

• iTonic Holdings (NASDAQ:ITOC) shares increased by 49.5% to $0.44 during Thursday's after-market session. The market value of their outstanding shares is at $5.1 million.
• Chemed (NYSE:CHE) shares moved upwards by 9.99% to $421.25. The market value of their outstanding shares is at $5.2 billion. As per the news, the Q1 earnings report came out today.
• Universe Pharmaceuticals (NASDAQ:UPC) shares moved upwards by 9.83% to $3.35. The company's market cap stands at $1.8 million.
• BiomX (AMEX:PHGE) stock moved upwards by 8.33% to $1.3. The market value of their outstanding shares is at $12.5 million.
• Tivic Health Systems (NASDAQ:TIVC) shares moved upwards by 7.14% to $1.2. The company's market cap stands at $3.2 million.
• Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 6.96% to $0.92. The market value of their outstanding shares is at $45.3 million.

Losers

• EUDA Health Holdings (NASDAQ:EUDA) shares declined by 14.1% to $9.84 during Thursday's after-market session. The market value of their outstanding shares is at $15.1 million.
• Advanced Biomed (NASDAQ:ADVB) stock fell 9.59% to $5.85. The market value of their outstanding shares is at $7.2 million.
• cbdMD (AMEX:YCBD) shares declined by 6.9% to $0.94. The company's market cap stands at $9.7 million.
• BNB Plus (NASDAQ:BNBX) stock fell 6.44% to $0.47. The company's market cap stands at $2.9 million.
• Theriva Biologics (AMEX:TOVX) stock fell 4.28% to $0.36. The company's market cap stands at $17.1 million.
• Retractable Technologies (AMEX:RVP) stock decreased by 4.28% to $0.62. The company's market cap stands at $19.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.